Soon, Irula community to get better returns for extracting venom

The NBA has already written to about 10 major biopharmaceutical companies to comply with the provisions of the Biodiversity Act (2014 guidelines).

Published: 05th August 2018 08:40 AM  |   Last Updated: 05th August 2018 08:40 AM   |  A+A-

The NBA has already written to about 10 major biopharmaceutical companies to comply with the provisions of the Biodiversity Act (2014 guidelines).

CHENNAI: The Irulas, India’s most experienced snake venom extractors, will soon be getting a better deal. The National Biodiversity Authority (NBA) and the Tamil Nadu Biodiversity Board have started the process of streamlining anti-venom production by bringing the biopharmaceutical companies, which buy venom stocks from Irulas, under Access and Benefit Sharing (ABS) of Biodiversity Act, 2002.

The NBA has already written to about 10 major biopharmaceutical companies to comply with the provisions of the Biodiversity Act (2014 guidelines). Once the ABS is fully enforced, the companies have to seek approval of the Tamil Nadu Biodiversity Board for access to the biological resource (snake venom).
If the company has a foreign connection, the NBA will give approval. Terms and conditions for access will be laid down in consultation with the Irula community and the block-level Biodiversity Management Committee.

As per the guidelines, when the biological resources are accessed for commercial utilisation, the manufacturer of anti-venom is obligated to pay a percentage of benefit sharing, ranging from 3-5 per cent of annual ex-factory sale of the product. T Rabikumar, secretary, NBA, said, “After we asked the companies to comply, one Hyderabad-based firm Biological E Limited has submitted an application and we are in the process of giving approval. Talks are being held with other companies too.”

Stay up to date on all the latest The Sunday Standard news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

facebook twitter whatsapp